United Therapeutics | UTHR - Market Capitalization

Stock Price
568.78
Daily Change
-7.01 -1.22%
Monthly
-2.02%
Yearly
86.27%
Q2 Forecast
553.25

United Therapeutics reported $27.1B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Baxter International USD 8.67B 1.15B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 8.44B 781M May/2026
Insmed USD 15.56B 19.73B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026